Alzheimer’s Disease/Dementia News

Compared to nonsmokers, quitters and minimal stable smokers did not have an increased risk. for cognitive decline, according to study results presented at the Alzheimer’s Association International Conference.

Patients who had a fusion of difficulties seeing, hearing and smelling were at increased risk for Alzheimer’s disease or dementia, according to study findings presented at the Alzheimer’s Association International Conference. A separate study also presented indicated that impaired sense of smell on particular odors may predict risk for dementia later in life.

Japanese older adults with diabetes or a BMI of less than 18.5 kg/m2 are more likely to develop dementia than those without either condition, according to findings published in the Journal of Diabetes Investigation.

Using statins was significantly associated with a decreased risk for mortality in dementia patients, according to research presented at the European Academy of Neurology Congress.

Older patients with incident atrial fibrillation had an increased risk for dementia independent of clinical stroke, according to a study published in the European Heart Journal.

The Infectious Diseases Society of America Foundation announced that it will award five one-time grants of $100,000 to researchers investigating a potential infectious cause of Alzheimer’s disease.

Multimorbidity using a validated index weighted to physical functioning was linked to faster decline in global cognition and verbal memory over time among U.S. middle-aged and older adults, according to data from a large nationally representative cohort study.

Elderly patients are at increased risk for cognitive decline and falls, yet these occurrences are often not brought up during appointments by either patients or health care providers, representing a significant number of missed opportunities to address issues of quality of life and potential morbidity associated with aging.

Older adults with incident cancer had higher memory function and slower memory decline before and after their diagnosis than similarly aged individuals who remained cancer free, a study published in JAMA Network Open showed.

Nilvadipine, a hypertension drug, increased cerebral blood flow to the hippocampus without affecting other brain regions among people with Alzheimer’s disease, study findings revealed.